# Deborah Ashby

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/deborah-ashby/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,015 |
| Field | SARS-CoV-2 and COVID-19 Research |
| h-index | 74 |
| i10-index | 198 |
| Last Known Institution | Imperial College London |
| OpenAlex ID | https://openalex.org/A5090829173 |
| ORCID iD | https://orcid.org/0000-0003-3146-7466 |
| Works | 322 |

## Researcher papers

- [Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial](https://scholariq.org/papers/rituximab-versus-intravenous-cyclophosphamide-in-patients-with-connective-tissue/)

## Researcher topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [COVID-19 epidemiological studies](https://scholariq.org/topics/covid-19-epidemiological-studies/)
- [SARS-CoV-2 detection and testing](https://scholariq.org/topics/sars-cov-2-detection-and-testing/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)

## Researcher university

- [Imperial College London](https://scholariq.org/institutions/imperial-college-london/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
